176 related articles for article (PubMed ID: 10395071)
1. Ala99ser mutation in RI alpha regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth.
Lee GR; Kim SN; Noguchi K; Park SD; Hong SH; Cho-Chung YS
Mol Cell Biochem; 1999 May; 195(1-2):77-86. PubMed ID: 10395071
[TBL] [Abstract][Full Text] [Related]
2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
Nesterova M; Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
[TBL] [Abstract][Full Text] [Related]
4. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.
Srivastava RK; Srivastava AR; Seth P; Agrawal S; Cho-Chung YS
Mol Cell Biochem; 1999 May; 195(1-2):25-36. PubMed ID: 10395066
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
Alper O; Hacker NF; Cho-Chung YS
Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
Nesterova MV; Cho-Chung YS
Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
[TBL] [Abstract][Full Text] [Related]
9. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells.
Telgmann R; Maronde E; Taskén K; Gellersen B
Endocrinology; 1997 Mar; 138(3):929-37. PubMed ID: 9048592
[TBL] [Abstract][Full Text] [Related]
10. Antisense depletion of RIalpha subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells.
Srivastava RK; Srivastava AR; Park YG; Agrawal S; Cho-Chung YS
Breast Cancer Res Treat; 1998 May; 49(2):97-107. PubMed ID: 9696392
[TBL] [Abstract][Full Text] [Related]
11. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
12. The differential response of protein kinase A to cyclic AMP in discrete brain areas correlates with the abundance of regulatory subunit II.
Ventra C; Porcellini A; Feliciello A; Gallo A; Paolillo M; Mele E; Avvedimento VE; Schettini G
J Neurochem; 1996 Apr; 66(4):1752-61. PubMed ID: 8627334
[TBL] [Abstract][Full Text] [Related]
13. Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression.
Cho YS; Park YG; Lee YN; Kim MK; Bates S; Tan L; Cho-Chung YS
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):835-40. PubMed ID: 10639166
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.
Scala S; Budillon A; Zhan Z; Cho-Chung YS; Jefferson J; Tsokos M; Bates SE
J Clin Invest; 1995 Aug; 96(2):1026-34. PubMed ID: 7543490
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts.
Tortora G; Budillon A; Yokozaki H; Clair T; Pepe S; Merlo G; Rohlff C; Cho-Chung YS
Cell Growth Differ; 1994 Jul; 5(7):753-9. PubMed ID: 7947390
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta.
Elliott MR; Shanks RA; Khan IU; Brooks JW; Burkett PJ; Nelson BJ; Kyttaris V; Juang YT; Tsokos GC; Kammer GM
J Immunol; 2004 Jun; 172(12):7804-12. PubMed ID: 15187164
[TBL] [Abstract][Full Text] [Related]
17. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.
Kim SN; Lee GR; Hwang ES; Lee JH; Park SD; Cho-Chung YS; Hong SH
Biochem Biophys Res Commun; 1997 Mar; 232(2):469-73. PubMed ID: 9125203
[TBL] [Abstract][Full Text] [Related]
18. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
Cho YS; Cho-Chung YS
Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
[TBL] [Abstract][Full Text] [Related]
19. Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction.
Kammer GM
Ann N Y Acad Sci; 2002 Jun; 968():96-105. PubMed ID: 12119270
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2.
Robinson-White A; Hundley TR; Shiferaw M; Bertherat J; Sandrini F; Stratakis CA
Hum Mol Genet; 2003 Jul; 12(13):1475-84. PubMed ID: 12812976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]